Evaluation of children with Crimean-Congo hemorrhagic fever in the central blacksea region

Pediatric Infectious Disease Journal

Volumn 33, Issue 8, 2014, Pages

  Belet, Nurşen ^a   Top, Ayşe ^a   Terzi, Özlem ^a   Arslan, Hatice Nilden ^a   Baysal, Kemal ^a   Şensoy, Gülnar ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Bradycardia; Children; Crimean Congo hemorrhagic fever; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN;

ADOLESCENT; BRADYCARDIA; CHILD; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; HUMAN; MALE; RETROSPECTIVE STUDY; TURKEY; VIROLOGY;

ADOLESCENT; ANTIVIRAL AGENTS; BRADYCARDIA; CHILD; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; HUMANS; MALE; RETROSPECTIVE STUDIES; RIBAVIRIN; TURKEY;

EID: 84905898450     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000281     Document Type: Article

References (29)

1. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-214.
2. Burt FJ, Leman PA, Smith JF, et al. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods. 1998;70:129-137.
3. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979;15:307-417.
4. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145-160.
5. Ergönül O, Celikbaş A, Dokuzoguz B, et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-287.
6. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-1384.
7. Bakir M, Ugurlu M, Dokuzoguz B, et al.; Turkish CCHF Study Group. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54(pt 4):385-389.
8. Bernstein D. Evaluation of the cardiovascular system. History and physical examination. In: Kliegman RM, Stanton BF, Schor NF, et al, eds. Texbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier;2011:1529-1537.
9. Lerner NB. Glader B. The anemias. In: Kliegman RM, Stanton BF, Schor NF, et al, eds. Texbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2011:1648-1650.
10. World Health Organization. Crimean-Congo hemorrhagic fever. Available at: www.who.int/inf-fs/fact208.html.
11. Dilber E, Cakir M, Acar EA, et al. Crimean-Congo haemorrhagic fever among children in north-eastern Turkey. Ann Trop Paediatr. 2009;29:23-28.
12. Tuygun N, Tanir G, Caglayik DY, et al. Pediatric cases of Crimean-Congo hemorrhagic fever in Turkey. Pediatr Int. 2012;54:402-406.
13. Tezer H, Sucakli IA, Sayli TR, et al. Crimean-Congo hemorrhagic fever in children. J Clin Virol. 2010;48:184-186.
14. Gul I, Kaya A, Güven AS, et al. Cardiac findings in children with Crimean-Congo hemorrhagic fever. Med Sci Monit. 2011;17: CR457-CR460.
15. Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52:207-215.
16. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, et al. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008;27:561-563.
17. Kaya A, Engin A, Güven AS, et al. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods. Int J Infect Dis. 2011;15:e449-e452.
18. S¸ensoy G, Çaltepe Dinler G, Kalkan G, et al. Crimean-Congo haemorrhagic fever: peritoneal and pleural effusion. Ann Trop Paediatr. 2011;31:169-172.
19. Tanir G, Tuygun N, Balaban I, et al. A case of Crimean-congo hemorrhagic fever with pleural effusion. Jpn J Infect Dis. 2009;62:70-72.
20. Duru F, Fişgin T. Hematological aspects of Crimean-Congo hemorrhagic fever. Turk J Hematol. 2009; 26:161-166.
21. Engin A, Yilmaz MB, Elaldi N, et al. Crimean-Congo hemorrhagic fever: does it involve the heart? Int J Infect Dis. 2009;13:369-373.
22. Yilmaz MB, Engin A, Bektasoglu G, et al. Does electrocardiography at admission predict outcome in Crimean-Congo hemorrhagic fever? J Vector Borne Dis. 2011;48:150-154.
23. Chiou HE, Liu CL, Buttrey MJ, et al. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest. 2005;128:263-272.
24. Mardani M, Rahnavardi M, Sharifi-Mood B. Current treatment of Crimean-Congo hemorrhagic fever in children. Expert Rev Anti Infect Ther. 2010;8:911-918.
25. Koksal I, Yilmaz G, Aksoy F, et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol. 2010;47:65-68.
26. Uysal B, Metan G. Bradycardia in a patient with Crimean-Congo hemorrhagic fever related to ribavirin treatment. J Vector Borne Dis. 2012;49:193-194.
27. Izadi S, Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis. 2009;62:11-15.
28. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11(suppl 4):S794-S800.
29. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374-379.